Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Advising leading-edge life sciences companies on transformational roll-up and $114m crossover financing

2021年3月10日

作者 Ross McNaughton 以及 Richard Faichney

点击此处了解更多
酒店与休闲

Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies

2021年2月16日

作者 Ross McNaughton 以及 Colin McCall

点击此处了解更多
技术、媒体与通信 (TMC)

Investment round for Cambridge quantum computing company

2021年2月10日

作者 Ross McNaughton 以及 Alex Dodds

点击此处了解更多
技术、媒体与通信 (TMC)

Advising Oxbotica in $47 million Series B investment

2021年1月15日

作者 Ross McNaughton 以及 Matt Harrison

点击此处了解更多

与我会面: